How is the Raman spectra working in the diagnosis of Glioma?
Best insight from top research papers
Raman spectroscopy plays a crucial role in the diagnosis of Glioma by providing real-time and accurate molecular information for tumor classification and boundary identification. Various studies have utilized Raman spectroscopy in conjunction with machine learning techniques like convolutional neural networks (CNN) and principal component analysis–support vector machine (PCA-SVM) to distinguish different grades of glioma, identify molecular subgroups, and predict the glioma methylome. The spectral differences between normal brain tissue and different grades of glioma have been successfully detected, enabling high accuracy in discriminating glioma tissues and guiding neurosurgeons in achieving maximal safe resection. Raman spectroscopy's ability to create molecular fingerprints of tumors and detect specific biomolecular changes, such as glycosylation patterns, makes it a promising tool for non-invasive and objective glioma diagnosis.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| Raman spectroscopy accurately classifies gliomas based on methylation subtypes, creating molecular fingerprints for diagnosis, enabling non-destructive analysis on FFPE tissue samples. | |
| Raman spectroscopy combined with machine learning analyzes glycosylation patterns to accurately discriminate between different grades of glioma in tissue, serum, and cellular models, aiding in glioma diagnosis. | |
| Raman spectra from VRR-LRRTM analyzer differentiate normal and glioma tissues, aiding intraoperative diagnosis with over 80% accuracy, guiding safe tumor resection and boundary identification. | |
| Raman spectra, aided by deep learning, accurately subgroup high-grade glioma based on molecular markers like IDH and 1p/19q, enabling real-time surgical guidance and personalized treatment decisions. | |
| Raman spectroscopy aids in accurately detecting glioma boundaries during surgery by utilizing a data augmentation method based on Gaussian kernel density, enhancing classification model accuracy despite limited normal tissue samples. |
Related Questions
Can Raman spectroscopy differentiate between normal brain tissue and glioma, cerebral metastasis, and primary CNS lymphoma?5 answersRaman spectroscopy has shown promise in differentiating between normal brain tissue and glioma, cerebral metastasis, and primary CNS lymphoma. Several studies have demonstrated the feasibility and accuracy of Raman spectroscopy in intraoperative guidance of tumor resection, with sensitivity ranging from 85.7% to 100% and specificity ranging from 90% to 100%. Raman spectroscopy has been found to be non-destructive, rapid, and accurate, allowing for excellent intraoperative identification of gliomas. The technique has also been used to assess glioma grades and identify tumor boundaries, aiding in the maximal safe resection of glioma and preservation of adjacent healthy tissue. In comparison to other visualization techniques, Raman spectroscopy has shown superior performance in predicting the presence of tumor, particularly in cases of glioblastoma, when compared to 5-aminolevulinic acid-induced fluorescence. Overall, Raman spectroscopy holds promise as a valuable tool for the diagnosis and treatment of brain diseases, including glioma, cerebral metastasis, and primary CNS lymphoma.
How is glioblastoma diagnosed?5 answersGlioblastoma (GBM) is diagnosed using various methods. Neuroimaging techniques, such as Terahertz, Infrared, and Raman spectroscopy, are commonly used for initial diagnosis. These techniques are followed by histopathological and molecular analysis of the resected or biopsied tissue to confirm the diagnosis. However, these methods have limitations, and alternative techniques such as liquid biopsy have emerged as non-invasive alternatives for GBM diagnosis. Liquid biopsy involves the detection and quantification of tumor-specific biomarkers in biofluids, primarily through blood tests. Circulating tumor DNA, circulating microRNAs, circulating tumor cells, extracellular vesicles, and circulating nucleosomes are some of the biomarkers that can be detected in the blood for GBM diagnosis. Proteomics methods and biosensors have also been used to detect biomarkers of GBM in biofluids. These advancements in diagnostic techniques aim to improve the diagnosis and monitoring of GBM patients.
What can Raman spectroscopy determine?5 answersRaman spectroscopy can determine various aspects in different fields. In the field of space exploration, it has been used to detect the presence of chlorides in brine samples, providing information about climate, water history, and deposition dynamics. In the pharmaceutical industry, Raman spectroscopy has been applied to determine the transition temperature of the β-relaxation and tertiary relaxation motions in amorphous drugs, aiding in estimating crystallization potency and understanding molecular dynamics. In the field of autoimmune diseases, Raman spectroscopy has shown potential as a cost-effective biomarker to discriminate active disease from remission in anti-neutrophil cytoplasmic autoantibody (ANCA) associated vasculitis, with high accuracy in discriminating disease activity. In clinical microbiology, Raman spectroscopy has been used for rapid detection and identification of different pathogens based on their unique spectra, allowing for the development of a new identification system. Additionally, Raman spectroscopy has been explored for the rapid and non-culture-based identification of pathogens and their antimicrobial resistance profile, potentially improving the management of infections and aiding in point-of-care diagnostics.
What are the challenges in accurate glioma detection and classification?5 answersAccurate glioma detection and classification face several challenges. One challenge is the laborious and error-prone manual delineation of diverse gliomas based on magnetic resonance imaging (MRI). The different phenotypes, sizes, and locations of gliomas make automatic segmentation difficult. Another challenge is tumor heterogeneity, which affects the design of effective and targeted therapies. Glioma-type identification relies on specific molecular and histological features defined by the WHO classification CNS, which is constantly updated. To address these challenges, various approaches have been proposed. These include deep learning for automatic multiclass classification of tumor grades, a 3D fully convolutional network with a dual-attention mechanism for segmenting diverse gliomas simultaneously, and a two-step variable selection approach for biomarker discovery based on RNA-sequencing data. These approaches aim to improve glioma detection and classification, support diagnosis and prognosis, and enhance the development of novel therapies.
How is Raman spectroscopy used for cancer?4 answersRaman spectroscopy is used for cancer in various ways. It allows for the classification of tumor tissues by obtaining biochemical maps of the tissues and observing changes in biochemical constituents. Raman spectroscopy has been successfully employed to differentiate blood samples from cancer patients versus healthy individuals, showing high sensitivity and the potential for early detection. In prostate cancer, Raman spectroscopy-based techniques offer a reliable tool for cancer detection, including biopsy analysis, assessment of surgical margins, and monitoring treatment efficacy. For gastric cancer, Raman spectroscopy has been studied for in vivo and in vitro diagnosis, tumor differentiation, and section pathology diagnosis. Raman spectroscopy provides specific chemical information that can be used for the early detection and diagnosis of cancer, monitoring treatment, and distinguishing between cancerous and non-cancerous samples.
Is Raman spectroscopy optical?7 answers